Molecular imaging of HER2 receptor: Targeting HER2 for imaging and therapy in nuclear medicine

Targeting HER 2 for imaging and therapy in nuclear medicine has been used with a special emphasis on developing more powerful radiopharmaceuticals. Zirconium-89 plays an essential role in immune PET imaging so was used labeled with anti-HER2 antibody (Trastuzumab and Pertuzumab). Also there were att...

Descripción completa

Detalles Bibliográficos
Autor principal: Miladinova, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018203/
https://www.ncbi.nlm.nih.gov/pubmed/36936995
http://dx.doi.org/10.3389/fmolb.2023.1144817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018203/
https://www.ncbi.nlm.nih.gov/pubmed/36936995
http://dx.doi.org/10.3389/fmolb.2023.1144817

Ejemplares similares